by John Conrad | Oct 4, 2024 | Uncategorized
Chicago-based biotech company receives FDA recognition for innovative spinal implant In a significant development for the field of regenerative medicine, Amphix Bio announced on October 3, 2024, that it has received Breakthrough Device designation from the U.S. Food...